World Library  
Flag as Inappropriate
Email this Article

Grifols

Article Id: WHEBN0016329119
Reproduction Date:

Title: Grifols  
Author: World Heritage Encyclopedia
Language: English
Subject: List of pharmaceutical manufacturers in the United Kingdom, Centennial Campus of North Carolina State University, Parets del Vallès, Enagás, Jazztel
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Grifols

Grifols, S.A.
Sociedad Anónima
Traded as BMAD: GRF
NASDAQ: GRFS
Industry Pharmaceuticals, chemicals
Founded 1940
Headquarters Barcelona, Spain
Key people
Víctor Grifols (Chairman and CEO)
Products Plasma derivatives, in vitro diagnostic products, non-biological products for laboratories and hospitals
Revenue Increase €2,741.732 million (2013)[1]
Increase €736.1 million (2013)[1]
Profit Increase €345.6 million (2013)[1]
Total assets Increase €7,276.1 million (june 2014)[1]
Total equity Increase €2,107.2 million (end 2013)[1]
Number of employees
Increase 11,779 (end 2013)[1]
Website www.grifols.com

Grifols, S.A. (Catalan: ) is a Spanish multinational pharmaceutical and chemical company. Principally a producer of blood plasma-based products, a field in which it is the European leader and largest worldwide,[2][3] the company also supplies devices, instruments and reagents for clinical testing laboratories.

Main products

Grifols is the major world supplier of IVIG, albumin, Factor VIII and other plasma-derived products.

Main operations

In 2007 the company had 3.6 million litres per year of blood fractionation capacity from three plants, one at Parets del Vallès near Barcelona in Spain (2.1 million litres per year), another in Los Angeles (1.5 million litres but being expanded to 2.2 million litres), and a site in Clayton,NC. In the United States the company owns 150 plasmapheresis centres, where it collects around 5.8 million litres of plasma per year.

Ownership

Grifols was listed on the Madrid Stock Exchange in May 2006.[4] The stock became part of the IBEX 35 index in January 2008.

History

Grifols was founded in 1940 in Barcelona by Dr José A. Grifols Roig, a hematologist and scientist. Dr Grifols was the first researcher to publish the plasmapheresis procedure in 1951. The company introduced its liquid IVIG product into the European market in the mid-1990s. In 2003 the company acquired certain assets of the Los Angeles-based Alpha Therapeutic as the basis of its American expansion.

On June 1, 2011, a year after announcing the $4 billion deal, Grifols completed a takeover of Talecris Biotherapeutics, headquartered in Research Triangle Park in North Carolina, with over 2000 employees.[5]

Grifols acquired the blood transfusion diagnostics unit from Novartis in 2013 as a "platform for global expansion".[3] This unit is based in Emeryville, California and was a part of Chiron acquired by Novartis in 2006.[3]

References

  1. 11 http://openaccess.uoc.edu/webapps/o2/bitstream/10609/13101/1/GRIFOLS%20Factores%20Competitividad%20a%20Largo%20Plazo.pdf
  1. ^ a b c d e f
  2. ^
  3. ^ a b c
  4. ^
  5. ^

External links

  • Official website
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.